Equity Investments
The Accelerator makes selective equity investments to support companies that are developing technologies with the potential to positively disrupt existing health solutions globally and especially at low cost in LMIC settings.
Select Filters
Domain
Subdomain
Investment Status
-
AI platform designing small RNAs
Eleven Therapeutic
Investment Status
Active, -
AI-enabled platform for insect control
Osmo Labs
Investment Status
Active, -
Breath biopsy platform for volatile detection
Investment Status
Active, -
Dendritic-cell-based mRNA vaccine for infectious diseases
Transimmune
Investment Status
Active, -
In vivo gene therapy for sickle cell disease
Investment Status
Active, -
Inhaled mRNA-based therapeutic for respiratory infections
Investment Status
Active, -
Inhaled mRNA-encoded antibodies for respiratory infections

Investment Status
Active, -
Low-cost oral biologics
Domain
Scalable Innovations in Biomanufacturing,Subdomain
Investment Status
Active, -
Nanobody-based platform to create novel vaccines
Investment Status
Active, -
Next generation digital olfaction platform for disease detection

Investment Status
Active,